38091211

https://pubmed.ncbi.nlm.nih.gov/38091211

Anti-calcitonin gene-related peptide monoclonal antibodies (anti-CGRP mAbs) are highly effective in reducing both the number of monthly aura days and headache days in individuals with migraine with aura.

Please note that this is an AI-generated summary and does not represent my views. For the actual PubMed abstract, please click on the provided PubMed link. This website aims to simplify and summarize PubMed abstracts, thereby disseminating scientific information from NCBI to the general public.